Alon Yaar
Directeur Général chez LIVEKIDNEY.BIO
Profil
Alon Yaar currently works at LIVEKIDNEY.BIO, as Chief Executive Officer & Board Member from 2018.
Dr. Yaar also formerly worked at Neuroptics, Inc., as CEO & BOARD MEMBER from 2017 to 2018, NeuroDerm Ltd., as COO, CEO and Board Member, Youdim Pharmaceuticals Ltd., as Chief Executive Officer from 2016 to 2017, N2b Ltd., as Chief Executive Officer, and Clal Life Sciences (CLS) LP, as Director-Preclinical Facilities.
Dr. Yaar received his graduate degree in 2012 from The College of Management Academic Studies and doctorate degree in 1994 from Universitat Autònoma de Barcelona.
Postes actifs de Alon Yaar
| Sociétés | Poste | Début |
|---|---|---|
LIVEKIDNEY.BIO
 LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Kidneycure Ltd. develops cell therapies to prevent progression of chronic kidney diseases. The company was founded by Benjamin and Dekel Orit Harari-Steinberg and is headquartered in Tel Aviv, Israel. | Directeur Général | 01/01/2018 |
Anciens postes connus de Alon Yaar
| Sociétés | Poste | Fin |
|---|---|---|
Neuroptics, Inc.
 Neuroptics, Inc. Medical SpecialtiesHealth Technology NeurOptics, Inc. provides neurological patient care services. It offers npi-100 pupillometer, an hand-held and cordless device that removes subjectivity in the measurement of pupil size and the pupillary light reflex. The company was founded by Kamran Siminou and is headquartered in Irvine, CA. | Directeur Général | 01/01/2018 |
Youdim Pharmaceuticals Ltd.
 Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel. | Directeur Général | 01/01/2017 |
| NEURODERM LTD | Directeur Général | 01/01/2008 |
N2b Ltd.
 N2b Ltd. Pharmaceuticals: MajorHealth Technology N2b Ltd. operates as a pharmaceutical company developing treatments for early Parkinsons disease. The firm offers intranasal delivery of rasagiline could combine useful alternative to oral administration in the treatment of PD and a novel therapeutic approach for the treatment of depression in PD patients. The company was founded in 2014 and is headquartered in Yokneam, Israel. | Directeur Général | - |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Corporate Officer/Principal | - |
Formation de Alon Yaar
| The College of Management Academic Studies | Graduate Degree |
| Universitat Autònoma de Barcelona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Neuroptics, Inc.
Neuroptics, Inc. Medical SpecialtiesHealth Technology NeurOptics, Inc. provides neurological patient care services. It offers npi-100 pupillometer, an hand-held and cordless device that removes subjectivity in the measurement of pupil size and the pupillary light reflex. The company was founded by Kamran Siminou and is headquartered in Irvine, CA. | Health Technology |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Youdim Pharmaceuticals Ltd.
Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel. | Finance |
Clal Life Sciences (CLS) LP
Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Finance |
N2b Ltd.
N2b Ltd. Pharmaceuticals: MajorHealth Technology N2b Ltd. operates as a pharmaceutical company developing treatments for early Parkinsons disease. The firm offers intranasal delivery of rasagiline could combine useful alternative to oral administration in the treatment of PD and a novel therapeutic approach for the treatment of depression in PD patients. The company was founded in 2014 and is headquartered in Yokneam, Israel. | Health Technology |
LIVEKIDNEY.BIO
LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Kidneycure Ltd. develops cell therapies to prevent progression of chronic kidney diseases. The company was founded by Benjamin and Dekel Orit Harari-Steinberg and is headquartered in Tel Aviv, Israel. | Commercial Services |